Diaceutics (DXRX)

Sector:

Health Care

Index:

FTSE AIM All-Share

107.00p
   
  • Change Today:
      3.00p
  • 52 Week High: 109.00
  • 52 Week Low: 80.50
  • Currency: UK Pounds
  • Shares Issued: 84.68m
  • Volume: 89,685
  • Market Cap: £90.61m
  • RiskGrade: 196

Diaceutics secures $1m subscription contract with 'leading life sciences company'

By Iain Gilbert

Date: Tuesday 14 Dec 2021

LONDON (ShareCast) - (Sharecast News) - Diagnostic commercialisation company Diaceutics said on Tuesday that it had secured a $1.0m contract with a "leading life sciences company" to provide data feed from its DXRX platform.
Diaceutics said the five-year subscription contract with the unnamed company, in which the firm was eligible for milestone payments in years one and three, demonstrated the demand for customised real-world data to support sales and marketing initiatives and the applicability of its offering to businesses outside of its core pharma customer base, while also supporting its move towards enhanced subscription-based revenues.

The AIM-listed group will deliver real-world data and insights on the demand for biomarkers customised to the client's needs across a number of diseases, with the information helping the mystery customer to identify important biomarker adoption trends and gaps which can support the commercialisation of new and existing diagnostics.

Chief executive and founder Peter Keeling said: "This multi-year deal demonstrates the confidence which one of the acknowledged global leaders in diagnostics has in the quality of our Deductive Diagnostic Pathways, and the strength of the DXRX platform.

"This agreement represents another step towards our recurring, high margin and scalable multi-year subscription revenue targets and reinforces our belief in the opportunity for the DXRX platform, to serve multiple stakeholders across healthcare industry unlock the promise of Precision Medicine."

As of 0945 GMT, Diaceutics shares were up 3.35% at 104.90p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Diaceutics Market Data

Currency UK Pounds
Share Price 107.00p
Change Today 3.00p
% Change 2.88 %
52 Week High 109.00
52 Week Low 80.50
Volume 89,685
Shares Issued 84.68m
Market Cap £90.61m
RiskGrade 196

Diaceutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
90.87% below the market average90.87% below the market average90.87% below the market average90.87% below the market average90.87% below the market average
81.25% below the sector average81.25% below the sector average81.25% below the sector average81.25% below the sector average81.25% below the sector average
Price Trend
45.03% above the market average45.03% above the market average45.03% above the market average45.03% above the market average45.03% above the market average
56.76% above the sector average56.76% above the sector average56.76% above the sector average56.76% above the sector average56.76% above the sector average
Income Not Available
Growth
2.91% above the market average2.91% above the market average2.91% above the market average2.91% above the market average2.91% above the market average
16.67% above the sector average16.67% above the sector average16.67% above the sector average16.67% above the sector average16.67% above the sector average

Diaceutics Dividends

No dividends found

Trades for 28-Mar-2024

Time Volume / Share Price
16:35 457 @ 107.00p
16:35 457 @ 107.00p
13:37 18,918 @ 104.50p
14:00 82 @ 104.00p
14:00 82 @ 104.00p

Diaceutics Key Personnel

CEO Ryan Gerard Keeling
CFO Nick Roberts

Top of Page